Sam Willcocks
- Epidemiology
- Molecular Biology
- Infectious Diseases top 10%
- Immunology
- Applied Microbiology and Biotechnology top 1%
- Co-authors
- Brendan W. WrenQuentin J. LeclercRumina HasanChristopher Finn McQuaidEsther van KleefClare ChandlerKarin GallandatGwenan M. Knight
- Topics
- Tuberculosis Research and Epidemiology (9 papers)Mycobacterium research and diagnosis (7 papers)Burkholderia infections and melioidosis (6 papers)
- Partner nations
- United KingdomGermanyThailand
In The Last Decade
Sam Willcocks
31 papers receiving 741 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Epidemiology 224
- Molecular Biology 220
- Infectious Diseases 176
- Immunology 142
- Applied Microbiology and Biotechnology 135
Countries citing papers authored by Sam Willcocks
This map shows the geographic impact of Sam Willcocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Willcocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Willcocks more than expected).
Fields of papers citing papers by Sam Willcocks
This network shows the impact of papers produced by Sam Willcocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Willcocks. The network helps show where Sam Willcocks may publish in the future.
Co-authorship network of co-authors of Sam Willcocks
This figure shows the co-authorship network connecting the top 25 collaborators of Sam Willcocks. A scholar is included among the top collaborators of Sam Willcocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Willcocks. Sam Willcocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 6 | |
| 4 | 15 | |
| 5 | 11 | |
| 6 | Antimicrobial resistance and COVID-19: Intersections and implicationsbreakdown → | 240 |
| 7 | 6 | |
| 8 | 12 | |
| 9 | 10 | |
| 10 | 14 | |
| 11 | 5 | |
| 12 | 8 | |
| 13 | 6 | |
| 14 | 21 | |
| 15 | 13 | |
| 16 | 10 | |
| 17 | 37 | |
| 18 | 85 | |
| 19 | 46 | |
| 20 | 25 |
About Sam Willcocks
Sam Willcocks is a scholar working on Molecular Medicine, Microbiology and Infectious Diseases, having authored 31 papers that have together received 755 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (7 papers) and Burkholderia infections and melioidosis (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (135 citations), Molecular Medicine (111 citations) and Microbiology (120 citations). Sam Willcocks has collaborated with scholars based in United Kingdom, Germany and Thailand. Frequent co-authors include Brendan W. Wren, Quentin J. Leclerc, Rumina Hasan, Christopher Finn McQuaid, Esther van Kleef, Clare Chandler, Karin Gallandat, Gwenan M. Knight, Naomi M. Fuller and R. E. Glover. Their work appears in journals such as PLoS ONE, Scientific Reports and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.